Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
J Neurol Sci ; 454: 120848, 2023 11 15.
Artigo em Inglês | MEDLINE | ID: mdl-37939626

RESUMO

INTRODUCTION: COVID-19 pandemic had a great impact on outcome in SARS-CoV-2 positive patients with ischemic stroke during the first wave in Italy. Few data are available on outcome stratified by sex. METHODS: The Italian Society of Hospital Neuroscience conducted a multi-center, retrospective, observational study on neurological complications in COVID-19 patients with ischemic stroke. All the patients admitted from March 1st to April 30th, 2020 in 20 Neurology Units in Northern Italy were recruited. Demographical and clinical features, treatment and outcome data were compared focusing on sex differences. RESULTS: 812 patients with ischemic stroke were enrolled, of whom 129 with COVID-19; males were 53.8%. In-hospital mortality in COVID-19 patients was 35.3% in males and 27.9% in females while 8.5% in male and 5.8% in female patients without COVID-19. SARS-CoV-2 positive patients had a higher frequency of stroke of undetermined etiology, than negative ones (32.8% vs 22.5%; p = 0.02), especially in females compared to males (36.1% vs 27.9%), albeit without statistical significance. Male patients with SARS-CoV-2 were more likely to require cPAP (30.9% vs 14.8%; p = 0.03), endotracheal tube (14.9% vs 3.3%; p = 0.02) and reperfusion strategies (29.4% vs 11.5%; p = 0.01) than females, as well as to have a higher CRP and D-dimer. These elements together with older age, a total anterior circulation stroke and lymphopenia were predictors of a worse outcome. DISCUSSION: Our study detected some differences due to sex in ischemic stroke with and without COVID-19, supporting the possibility to perform sex analyses for SARS-CoV-2 positive patients for a better clinical management.


Assuntos
COVID-19 , AVC Isquêmico , Acidente Vascular Cerebral , Humanos , Feminino , Masculino , COVID-19/epidemiologia , SARS-CoV-2 , AVC Isquêmico/epidemiologia , Estudos Retrospectivos , Pandemias , Caracteres Sexuais , Acidente Vascular Cerebral/terapia , Itália/epidemiologia
2.
J Neurol Sci ; 426: 117479, 2021 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-34004463

RESUMO

INTRODUCTION: Growing evidence has been published as to the impact of SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) on cerebrovascular events over the last few months, with considerable attention paid to ischemic strokes. Conversely, little is known about the clinical course of intracerebral haemorrhage (ICH) and simultaneous SARS-CoV-2 infection. METHOD: The Italian Society of Hospital Neurosciences (SNO) promoted a multicentre, retrospective, observational study (SNO-COVID-19), involving 20 Neurological Departments in Northern Italy. Clinical data on patients with acute cerebrovascular diseases, admitted from March 1st to April 30th, 2020, were collected. A comparison was made of the demographical and clinical features of both SARS-CoV-2 positive and negative patients with ICH. RESULTS: 949 patients were enrolled (average age 73.4 years; 52.7% males); 135 patients had haemorrhagic stroke and 127 (13.4%) had a primary ICH. Only 16 patients with ICH (12.6%) had laboratory confirmed SARS-CoV-2 infection, both symptomatic and asymptomatic. SARS-CoV-2 related pneumonia or respiratory distress (OR 5.4), lobar location (OR 5.0) and previous antiplatelet or anticoagulant treatment (OR 2.9) were the only factors significantly associated with increased mortality in ICH. SARS-CoV-2 infection, regardless of respiratory involvement, led to a non-significantly increased risk of in-hospital death (37.5% vs 23.4%, p = 0.2). DISCUSSION: ICH patients with COVID-19 did not experience an increase in mortality as striking as ischemic stroke. The inflammatory response and respiratory complications could justify the slight increase of death in ICH. Bleeding sites and previous antiplatelet or anticoagulant treatment were the only other predictors of a worse outcome.


Assuntos
COVID-19 , SARS-CoV-2 , Idoso , Hemorragia Cerebral/complicações , Hemorragia Cerebral/epidemiologia , Feminino , Mortalidade Hospitalar , Humanos , Itália/epidemiologia , Masculino , Estudos Retrospectivos
3.
Neurol Sci ; 29(3): 163-7, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18612764

RESUMO

Posterior reversible encephalopathy is a distinctive syndrome associated with different diseases and drugs. Disease evolution is frequently favorable with an adequate treatment. Damage typically involves parietal-occipital lobes even if a more anterior diffusion has been described. Here, we report the case of a woman affected by Polyarteritis Nodosa, who suddenly complicated with decreased consciousness and seizures, during an acute hypertensive state. MRI imaging showed increased T2 and FLAIR signal in posterior regions. Her neurological evolution was positive, according to arterial pressure correction, although the systemic vasculitis was still ongoing, hence affecting final prognosis.


Assuntos
Encéfalo/patologia , Artérias Cerebrais/patologia , Poliarterite Nodosa/complicações , Poliarterite Nodosa/patologia , Síndrome da Leucoencefalopatia Posterior/etiologia , Síndrome da Leucoencefalopatia Posterior/patologia , Injúria Renal Aguda/etiologia , Injúria Renal Aguda/fisiopatologia , Encéfalo/irrigação sanguínea , Encéfalo/fisiopatologia , Artérias Cerebrais/fisiopatologia , Progressão da Doença , Evolução Fatal , Feminino , Humanos , Imunossupressores/uso terapêutico , Imageamento por Ressonância Magnética , Artéria Mesentérica Superior/diagnóstico por imagem , Artéria Mesentérica Superior/patologia , Artéria Mesentérica Superior/fisiopatologia , Pessoa de Meia-Idade , Poliarterite Nodosa/fisiopatologia , Síndrome da Leucoencefalopatia Posterior/fisiopatologia , Prognóstico , Radiografia , Artéria Renal/patologia , Artéria Renal/fisiopatologia , Falha de Tratamento , Vasculite do Sistema Nervoso Central/etiologia , Vasculite do Sistema Nervoso Central/patologia , Vasculite do Sistema Nervoso Central/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA